2689-69-2 Usage
Description
METHYL 3-OXOTETRAHYDROTHIOPHENE-2-CARBOXYLATE is an organic compound with the molecular formula C6H10O3S. It is a key intermediate in the synthesis of various chemical compounds, particularly in the production of dihydro-thiophen-3-one derivatives. METHYL 3-OXOTETRAHYDROTHIOPHENE-2-CARBOXYLATE plays a significant role in the chemical and pharmaceutical industries due to its versatile reactivity and potential applications.
Uses
Used in Chemical Synthesis:
METHYL 3-OXOTETRAHYDROTHIOPHENE-2-CARBOXYLATE is used as a key intermediate for the production of dihydro-thiophen-3-one. This application is crucial in the chemical industry as dihydro-thiophen-3-one and its derivatives have a wide range of uses, including the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, METHYL 3-OXOTETRAHYDROTHIOPHENE-2-CARBOXYLATE is used as a building block for the development of novel therapeutic agents. The compound's unique structure allows for the creation of new molecules with potential biological activities, which can be further explored for their use in treating various diseases and medical conditions.
Used in Agrochemical Industry:
METHYL 3-OXOTETRAHYDROTHIOPHENE-2-CARBOXYLATE also finds application in the agrochemical industry, where it is utilized in the synthesis of new compounds with pesticidal, herbicidal, or fungicidal properties. These compounds can be developed into more effective and environmentally friendly agrochemicals to improve crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 2689-69-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,8 and 9 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2689-69:
(6*2)+(5*6)+(4*8)+(3*9)+(2*6)+(1*9)=122
122 % 10 = 2
So 2689-69-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H8O3S/c1-9-6(8)5-4(7)2-3-10-5/h5H,2-3H2,1H3
2689-69-2Relevant articles and documents
-
Erastov,Ignat'eva
, (1971)
-
Development of a Practical Process for the Synthesis of PDE4 Inhibitors
Frutos, Rogelio P.,Tampone, Thomas G.,Mulder, Jason A.,Rodriguez, Sonia,Yee, Nathan K.,Yang, Bing-Shiou,Senanayake, Chris H.
, p. 982 - 988 (2016/06/09)
A practical, safe, and efficient process for the synthesis of PDE4 (phosphodiesterase type 4) inhibitors represented by 1 and 2 was developed and demonstrated on a multi-kilogram scale. Key aspects of the process include the regioselective synthesis of dihydrothieno[3,2-d]pyrimidine-2,4-diol 9 and the asymmetric sulfur oxidation of intermediate 11.
SPECIFIC PDE4B-INHIBITORS FOR THE TREATMENT OF DIABETES MELLITUS
-
Paragraph 0240-0241, (2014/08/19)
A method of treating diabetes mellitus or a microvascular or macrovascular complication of diabetes mellitus in a patient in need thereof, the method comprising administering to the patient a compound of formula 1 wherein R1, R2, R3, and R4 are as defined in claim 1.
MORPHOLINO SUBSTITUTED BICYCLIC PYRIMIDINE UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS
-
Page/Page column 44; 62, (2013/04/24)
The invention relates to compounds of formula (I) wherein m, o, Ra, Rb, R1 and T1 have the meaning as cited in the description and the claims. Said compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR related diseases and disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments
